Hypnotizability and Placebo Analgesia in Waking and Hypnosis as Modulators of Auditory Startle Responses in Healthy Women: An ERP Study

PLOS ONE, Dec 2019

We evaluated the influence of hypnotizability, pain expectation, placebo analgesia in waking and hypnosis on tonic pain relief. We also investigated how placebo analgesia affects somatic responses (eye blink) and N100 and P200 waves of event-related potentials (ERPs) elicited by auditory startle probes. Although expectation plays an important role in placebo and hypnotic analgesia, the neural mechanisms underlying these treatments are still poorly understood. We used the cold cup test (CCT) to induce tonic pain in 53 healthy women. Placebo analgesia was initially produced by manipulation, in which the intensity of pain induced by the CCT was surreptitiously reduced after the administration of a sham analgesic cream. Participants were then tested in waking and hypnosis under three treatments: (1) resting (Baseline); (2) CCT-alone (Pain); and (3) CCT plus placebo cream for pain relief (Placebo). For each painful treatment, we assessed pain and distress ratings, eye blink responses, N100 and P200 amplitudes. We used LORETA analysis of N100 and P200 waves, as elicited by auditory startle, to identify cortical regions sensitive to pain reduction through placebo and hypnotic analgesia. Higher pain expectation was associated with higher pain reductions. In highly hypnotizable participants placebo treatment produced significant reductions of pain and distress perception in both waking and hypnosis condition. P200 wave, during placebo analgesia, was larger in the frontal left hemisphere while placebo analgesia, during hypnosis, involved the activity of the left hemisphere including the occipital region. These findings demonstrate that hypnosis and placebo analgesia are different processes of top-down regulation. Pain reduction was associated with larger EMG startle amplitudes, N100 and P200 responses, and enhanced activity within the frontal, parietal, and anterior and posterior cingulate gyres. LORETA results showed that placebo analgesia modulated pain-responsive areas known to reflect the ongoing pain experience.

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0159135&type=printable

Hypnotizability and Placebo Analgesia in Waking and Hypnosis as Modulators of Auditory Startle Responses in Healthy Women: An ERP Study

August Hypnotizability and Placebo Analgesia in Waking and Hypnosis as Modulators of Auditory Startle Responses in Healthy Women: An ERP Study Vilfredo De Pascalis 0 1 2 Paolo Scacchia 0 1 2 0 La Sapienza University of Rome , Rome , Italy 1 Funding: This study was supported by an annual grant (Ricerche Universitarie, 2015-prot. C26A15RC5R) from the "La Sapienza" University of Rome 2 Editor: Alexandra Key, Vanderbilt University , UNITED STATES We evaluated the influence of hypnotizability, pain expectation, placebo analgesia in waking and hypnosis on tonic pain relief. We also investigated how placebo analgesia affects somatic responses (eye blink) and N100 and P200 waves of event-related potentials (ERPs) elicited by auditory startle probes. Although expectation plays an important role in placebo and hypnotic analgesia, the neural mechanisms underlying these treatments are still poorly understood. We used the cold cup test (CCT) to induce tonic pain in 53 healthy women. Placebo analgesia was initially produced by manipulation, in which the intensity of pain induced by the CCT was surreptitiously reduced after the administration of a sham analgesic cream. Participants were then tested in waking and hypnosis under three treatments: (1) resting (Baseline); (2) CCT-alone (Pain); and (3) CCT plus placebo cream for pain relief (Placebo). For each painful treatment, we assessed pain and distress ratings, eye blink responses, N100 and P200 amplitudes. We used LORETA analysis of N100 and P200 waves, as elicited by auditory startle, to identify cortical regions sensitive to pain reduction through placebo and hypnotic analgesia. Higher pain expectation was associated with higher pain reductions. In highly hypnotizable participants placebo treatment produced significant reductions of pain and distress perception in both waking and hypnosis condition. P200 wave, during placebo analgesia, was larger in the frontal left hemisphere while placebo analgesia, during hypnosis, involved the activity of the left hemisphere including the occipital region. These findings demonstrate that hypnosis and placebo analgesia are different processes of top-down regulation. Pain reduction was associated with larger EMG startle amplitudes, N100 and P200 responses, and enhanced activity within the frontal, parietal, and anterior and posterior cingulate gyres. LORETA results showed that placebo analgesia modulated pain-responsive areas known to reflect the ongoing pain experience. - OPEN ACCESS Data Availability Statement: All relevant data are within the paper and its Supporting Information files. Competing Interests: The authors have declared that no competing interests exist. Introduction Human pain is a potent stressor with immediate relevance to survival and is believed to be a multi-faceted protective experience involving the activity of sensory-discriminative, affectiveemotional, attentional-cognitive, behavioral and social learning systems [ 1–3 ]. Multiple psychological factors have been suggested to modulate the magnitude of pain, i.e., past experience [ 4, 5 ], classical conditioning [ 6–13 ], suggestibility [ 14, 15 ], expectancy [16], and ritualistic therapeutic acts [ 14, 17, 18 ]. This type of modulation is believed to happen through a top-down neurophysiological process that, when activated by one or more of the above mentioned factors, may produce neurophysiological changes that affect pain perception. The use of placebos and hypnosis represents two ways of how the top-down control can modulate pain perception, but the research of placebo and hypnosis often follows two separate tracks and their neurobiological similarities and differences are yet not fully understood. We have known, for a long time, that hypnotic analgesia is not a variant on placebo analgesia since highly hypnotizable individuals report feeling less pain during hypnosis than during placebo condition [ 19 ], suggesting that the effects of placebo and hypnosis analgesia are at least in part separate processes. A recent literature review on brain activity changes to placebo and hypnotic analgesia has highlighted similarities and differences between these two treatments [ 20 ]. First, these treatments produce similar changes in the activity of a number of brain regions labeled as pain network (i.e., somatosensory cortex, ACC, insula, thalamus, and prefrontal cortex). The activation of prefrontal cortex is necessary for cognitive evaluation and plays a leading role during both placebo and hypnotic analgesia treatments [ 21–24 ]. Pain relief elicited through these treatments are mediated by dopaminergic activity in the prefrontal cortex [ 25–28 ] and caused by changes in expectation [ 29, 30 ]. Second, the major differences between these two treatments lie in the fact that placebo analgesia produces functional changes in several parts of the limbic system (i.e., amygdala, hypothalamus and hippocampus, periaqueductal gray, nucleus accum (...truncated)


This is a preview of a remote PDF: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0159135&type=printable

Vilfredo De Pascalis, Paolo Scacchia. Hypnotizability and Placebo Analgesia in Waking and Hypnosis as Modulators of Auditory Startle Responses in Healthy Women: An ERP Study, PLOS ONE, 2016, Volume 11, Issue 8, DOI: 10.1371/journal.pone.0159135